HOOKIPA Pharma Statistics

Total Valuation

HOOKIPA Pharma has a market cap or net worth of $21.89 million. The enterprise value is -$17.79 million.

Market Cap	21.89M
Enterprise Value	-17.79M

Important Dates

The last earnings date was Thursday, May 15, 2025, after market close.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

HOOKIPA Pharma has 12.54 million shares outstanding. The number of shares has increased by 16.46% in one year.

Current Share Class	9.66M
Shares Outstanding	12.54M
Shares Change (YoY)	+16.46%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	0.12%
Owned by Institutions (%)	23.12%
Float	9.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.34
Forward PS	n/a
PB Ratio	0.51
P/TBV Ratio	0.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.61, with a Debt / Equity ratio of 0.02.

Current Ratio	3.61
Quick Ratio	2.92
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -105.79% and return on invested capital (ROIC) is -64.45%.

Return on Equity (ROE)	-105.79%
Return on Assets (ROA)	-45.20%
Return on Invested Capital (ROIC)	-64.45%
Return on Capital Employed (ROCE)	-167.87%
Revenue Per Employee	$107,483
Profits Per Employee	-$842,678
Employee Count	87
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	-106,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -78.54% in the last 52 weeks. The beta is 0.75, so HOOKIPA Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	-78.54%
50-Day Moving Average	1.11
200-Day Moving Average	2.67
Relative Strength Index (RSI)	71.43
Average Volume (20 Days)	157,155

Short Selling Information

The latest short interest is 29,869, so 0.24% of the outstanding shares have been sold short.

Short Interest	29,869
Short Previous Month	12,919
Short % of Shares Out	0.24%
Short % of Float	0.31%
Short Ratio (days to cover)	0.78

Income Statement

In the last 12 months, HOOKIPA Pharma had revenue of $9.35 million and -$73.31 million in losses. Loss per share was -$5.84.

Revenue	9.35M
Gross Profit	-57.78M
Operating Income	-74.90M
Pretax Income	-48.43M
Net Income	-73.31M
EBITDA	-72.40M
EBIT	-74.90M
Loss Per Share	-$5.84

Full Income Statement

Balance Sheet

The company has $40.28 million in cash and $596,000 in debt, giving a net cash position of $39.68 million or $3.16 per share.

Cash & Cash Equivalents	40.28M
Total Debt	596,000
Net Cash	39.68M
Net Cash Per Share	$3.16
Equity (Book Value)	34.08M
Book Value Per Share	3.44
Working Capital	43.45M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$52.77 million and capital expenditures -$98,000, giving a free cash flow of -$52.87 million.

Operating Cash Flow	-52.77M
Capital Expenditures	-98,000
Free Cash Flow	-52.87M
FCF Per Share	-$4.21

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-801.02%
Pretax Margin	-785.15%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HOOKIPA Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.46%
Shareholder Yield	-16.46%
Earnings Yield	-334.95%
FCF Yield	-241.54%

Analyst Forecast

The average price target for HOOKIPA Pharma is $10.67, which is 511.46% higher than the current price. The consensus rating is "Buy".

Price Target	$10.67
Price Target Difference	511.46%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	-14.23%
EPS Growth Forecast (5Y)	-12.00%

Stock Forecasts

Stock Splits

The last stock split was on July 10, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jul 10, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1